Search Result

Results for "

Apolipoprotein

" in MedChemExpress (MCE) Product Catalog:

By Targets:	Apolipoprotein (12) Amino Acid Derivatives (2) Apoptosis (2) Calmodulin (1) Endogenous Metabolite (4) FABP (2) HCV (2) nAChR (2) Small Interfering RNA (siRNA) (2) VEGFR (1)
By Research Areas:	Cancer (5) Cardiovascular Disease (15) Endocrinology (2) Infection (1) Inflammation/Immunology (10) Metabolic Disease (4) Neurological Disease (8)
Oligonucleotides:	Antisense Oligonucleotides (8) siRNAs (2)

Inhibitors & Agonists

Peptides

Natural
Products

Recombinant Proteins

Isotope-Labeled Compounds

Antibodies

Oligonucleotides

Targets Recommended: Apolipoprotein

Cat. No.	Product Name	Target	Research Areas	Chemical Structure

HY-147425A

Zerlasiran sodium SLN360 sodium	Small Interfering RNA (siRNA) Apolipoprotein	Cardiovascular Disease
Zerlasiran sodium is an apolipoprotein A (ApoA) synthesis reducer .

HY-132820

Inaxaplin VX-147	Apolipoprotein	Others
Inaxaplin (VX-147) is an orally active apolipoprotein L1 (APOL1) function inhibitor (WO2020131807, compound 2). Inaxaplin can be used for the research of kidney disease .

HY-P2136

COG1410 1 Publications Verification	Apoptosis	Neurological Disease Inflammation/Immunology
COG1410 is an apolipoprotein E-derived peptide and an apoptosis inhibitor. COG1410 exerts neuroprotective and antiinflammatory effects in a murine model of traumatic brain injury (TBI). COG1410 can be used for the research of neurological disease .

HY-141885

APOL1-IN-1	Apolipoprotein	Metabolic Disease
APOL1-IN-1 is a **apolipoprotein L1 (APOL1)** inhibitor extracted from patent WO2020131807A1 compound 87. APOL1-IN-1 can be used for the research of focal segmental glomerulosclerosis (FSGS) and non-diabetic kidney disease (NDKD) .

HY-103076

EZ-482 1 Publications Verification	Apolipoprotein	Neurological Disease
EZ-482, a novel ligand of apolipoprotein (apoE), binds to sites on apoE in the C-terminal domain with K_ds of 5-10 μM for apoE3 and apoE4. EZ-482 binds to apoE4 by a unique N-terminal allosteric effect. EZ482 has the potential for Alzheimer’s diseas .

HY-P10521

Apolipoprotein KV domain (67-77)	VEGFR	Cancer
Apolipoprotein KV domain (67-77) is an 11-amino acid peptide identified from the KV domain of human apolipoprotein a (ApoA) with antiangiogenic and antitumor activities. Apolipoprotein KV domain (67-77) targets the angiogenic c-Src/ERK pathway by blocking activation signals received from vascular endothelial growth factor (VEGF). Apolipoprotein KV domain (67-77) can be used in cancer research .

HY-147425

Zerlasiran SLN360	Small Interfering RNA (siRNA) Apolipoprotein	Cardiovascular Disease
Zerlasiran is an apolipoprotein A (ApoA) synthesis reducer .

HY-153491

Olezarsen ISIS 678354; IONIS-APOCIII-LRx; AKCEA-APOCIII-LRx	Apolipoprotein	Cardiovascular Disease
Olezarsen is an N-acetyl-galactosamine-conjugated antisense oligonucleotide targeted to hepatic APOC3 mRNA to inhibit apolipoprotein C-III (apoC-III) production, in lowering triglyceride levels in patients at high risk for or with established cardiovascular disease.

HY-P5169

LVGRQLEEFL (mouse)	Amino Acid Derivatives	Inflammation/Immunology
LVGRQLEEFL (mouse) can be named as G * peptide, corresponding to amino acids 113 to 122 in apolipoprotein J ([113,122] apoJ)}. LVGRQLEEFL (mouse) exhibits anti-inflammatory and anti-atherogenic properties. LVGRQLEEFL (mouse) can be added to an apoJ mimetic, to form HM-10/10 peptide, which is a mimetic peptide and a novel chimeric high density lipoprotein. HM-10/10 peptide protects retinal pigment epithelium (RPE) and photoreceptors from oxidant induced cell death .

HY-P5169A

LVGRQLEEFL (mouse) (TFA)	Amino Acid Derivatives	Inflammation/Immunology
LVGRQLEEFL (mouse) TFA can be named as G * peptide, corresponding to amino acids 113 to 122 in apolipoprotein J ([113,122] apoJ)}. LVGRQLEEFL (mouse) TFA exhibits anti-inflammatory and anti-atherogenic properties. LVGRQLEEFL (mouse) TFA can be added to an apoJ mimetic, to form HM-10/10 peptide, which is a mimetic peptide and a novel chimeric high density lipoprotein. HM-10/10 peptide protects retinal pigment epithelium (RPE) and photoreceptors from oxidant induced cell death .

HY-145727A

Volanesorsen sodium ISIS 304801 sodium	Apolipoprotein	Endocrinology
Volanesorsen sodium is an antisense oligonucleotide thay targes Apolipoprotein C-III (APOC3) mRNA. Volanesorsen sodium is used for the study of familial chylomicronemia syndrome.

HY-112798

PH-002	Apolipoprotein	Neurological Disease
PH-002 is an inhibitor of apolipoprotein (apo) E4 intramolecular domain interaction in neuronal cells that could rescue impairments of mitochondrial motility and neurite outgrowth.

HY-108764

Mipomersen sodium ISIS 301012	Apolipoprotein HCV	Metabolic Disease
Mipomersen sodium (ISIS 301012) is an antisense oligonucleotide inhibitor of apolipoprotein B (apoB). Mipomersen has anti-HCV effect and reduces the infectivity of the HCV. Mipomersen sodium can be used for the research of homozygous familial hypercholesterolemia (HoFH) .

HY-153491A

Olezarsen sodium ISIS 678354 sodium; IONIS-APOCIII-LRx sodium; AKCEA-APOCIII-LRx sodium	Apolipoprotein	Cardiovascular Disease
Olezarsen sodium is an N-acetyl-galactosamine-conjugated antisense oligonucleotide targeted to hepatic APOC3 mRNA to inhibit apolipoprotein C-III (apoC-III) production, in lowering triglyceride levels in patients at high risk for or with established cardiovascular disease.

HY-P1050

COG 133	nAChR	Neurological Disease Inflammation/Immunology
COG 133 is a fragment of Apolipoprotein E (APOE) peptide. COG 133 competes with the ApoE holoprotein for binding the LDL receptor, with potent anti-inflammatory and neuroprotective effects. COG 133 is also a nAChR antagonist with an IC₅₀ of 445 nM .

HY-148647

Mipomersen ISIS 301012 free base	Apolipoprotein HCV	Infection
Mipomersen (ISIS 301012 free base) is an antisense oligonucleotide inhibitor of apolipoprotein B (apoB). Mipomersen has anti-HCV effect and reduces the infectivity of the HCV. Mipomersen can be used for the research of homozygous familial hypercholesterolemia (HoFH) .

HY-W590664

C2 Dihydroceramide	Endogenous Metabolite	Cardiovascular Disease
C2 Dihydroceramide is a derivative of C2 Ceramide (HY-101180). C2 Dihydroceramide enhances the ABCA1-mediated cholesterol efflux to apolipoprotein A-I (apoA-I) without causing cytotoxicity .

HY-19418

KRP-101	Others	Others
KRP-101 is a compound that regulates the expression of genes related to lipid metabolism. It is a PPARα agonist that can highly sensitively regulate the expression of genes such as apolipoprotein A-IV, which may be related to lowering serum triglycerides and increasing HDL.

HY-A0143

Dihomo-γ-linolenic acid 3 Publications Verification DGLA; all-cis-8,11,14-Eicosatrienoic acid	Endogenous Metabolite	Cardiovascular Disease Inflammation/Immunology Cancer
Dihomo-γ-linolenic acid (DGLA) is a 20-carbon ω-6 fatty acid, with anti-inflammatory and anti-proliferative activities. Dihomo-γ-linolenic acid attenuates atherosclerosis in the apolipoprotein E deficient mouse model system .

HY-P1050A

COG 133 TFA 1 Publications Verification	nAChR	Neurological Disease Inflammation/Immunology
COG 133 TFA is a fragment of Apolipoprotein E (APOE) peptide. COG 133 TFA competes with the ApoE holoprotein for binding the LDL receptor, with potent anti-inflammatory and neuroprotective effects. COG 133 TFA is also a nAChR antagonist with an IC₅₀ of 445 nM .

HY-145727

Volanesorsen ISIS 304801	Apolipoprotein	Endocrinology
Volanesorsen (ISIS 304801) is an antisense oligonucleotide inhibitor of apolipoprotein CIII (apo-CIII) mRNA that reduces triglyceride levels and improves insulin resistance. Volanesorsen is being studied in the treatment of hypertriglyceridemia, familial chylosiderosis syndrome, and type 2 diabetes .

HY-A0143A

Dihomo-γ-linolenic acid sodium DGLA sodium; all-cis-8,11,14-Eicosatrienoic acid sodium	Endogenous Metabolite	Cardiovascular Disease Inflammation/Immunology Cancer
Dihomo-γ-linolenic acid (DGLA; all-cis-8,11,14-Eicosatrienoic acid) sodium is a 20-carbon ω-6 fatty acid, with anti-inflammatory and anti-proliferative activities. Dihomo-γ-linolenic acid (sodium) attenuates atherosclerosis in the apolipoprotein E deficient mouse model system .

HY-P2136F

Biotin-COG1410 TFA	Apoptosis	Neurological Disease Inflammation/Immunology Cancer
Biotin-COG1410 TFA is a biotin labled COG1410 (HY-P2136). COG1410 is an apolipoprotein E-derived peptide and an apoptosis inhibitor. COG1410 exerts neuroprotective and antiinflammatory effects in a murine model of traumatic brain injury (TBI). COG1410 can be used for the research of neurological disease .

HY-169080

ABCA1 inducer 1	Others	Neurological Disease
ABCA1 inducer 1 is a nonlipogenic ABCA1 inducer. ABCA1 inducer 1 increases ABCA1 expression, enhances apolipoprotein (APOE) lipidation and reverses multiple Alzheimer’s disease (AD) phenotypes, without increasing triglycerides in E3/4FAD mice that express human APOE 3/4 .

HY-A0143S

Dihomo-γ-linolenic acid-d6 DGLA-d₆; all-cis-8,11,14-Eicosatrienoic acid-d₆	Endogenous Metabolite	Cardiovascular Disease Inflammation/Immunology Cancer
Dihomo-γ-linolenic acid-d₆ (DGLA-d₆) is the deuterium labeled Dihomo-γ-linolenic acid. Dihomo-γ-linolenic acid (all-cis-8,11,14-Eicosatrienoic acid) is a 20-carbon ω-6 fatty acid, with anti-inflammatory and anti-proliferative activities. Dihomo-γ-linolenic acid attenuates atherosclerosis in the apolipoprotein E deficient mouse model system[1][2][3].

HY-101903

BMS-309403 Maximum Cited Publications 14 Publications Verification	FABP	Cardiovascular Disease Metabolic Disease
BMS-309403 is a potent, orally active and selective adipocyte fatty acid binding protein (also known as FABP4, aP2) inhibitor with K_is of <2, 250, and 350 nM for FABP4, FABP3, and FABP5, respectively. BMS-309403 interacts with the fatty-acid-binding pocket within the interior of the protein and competitively inhibits the binding of endogenous fatty acids. BMS-309403 improves endothelial function in apolipoprotein E-deficient mice and in cultured human endothelial cells .

HY-101903A

BMS-309403 sodium Maximum Cited Publications 14 Publications Verification	FABP	Cardiovascular Disease Metabolic Disease
BMS-309403 sodium is a potent, orally active, and selective adipocyte fatty acid binding protein (also known as FABP4, aP2) inhibitor, with K_is of <2, 250, and 350 nM for FABP4, FABP3, and FABP5, respectively. BMS-309403 sodium interacts with the fatty-acid-binding pocket within the interior of the protein and competitively inhibits the binding of endogenous fatty acids. BMS-309403 sodium improves endothelial function in apolipoprotein E-deficient mice and in cultured human endothelial cells .

HY-100911

W-5 hydrochloride	Calmodulin	Neurological Disease
W-5 hydrochloride is a calmodulin antagonist. W-5 hydrochloride inhibits phosphodiesterase activation with an IC₅₀ value of 240 µM. W-5 hydrochloride can be used as a negative control for W-7 (HY-100912) .

Cat. No.	Product Name	Target	Research Area

HY-P2136

COG1410 1 Publications Verification	Apoptosis	Neurological Disease Inflammation/Immunology
COG1410 is an apolipoprotein E-derived peptide and an apoptosis inhibitor. COG1410 exerts neuroprotective and antiinflammatory effects in a murine model of traumatic brain injury (TBI). COG1410 can be used for the research of neurological disease .

HY-P1050A

COG 133 TFA 1 Publications Verification	nAChR	Neurological Disease Inflammation/Immunology
COG 133 TFA is a fragment of Apolipoprotein E (APOE) peptide. COG 133 TFA competes with the ApoE holoprotein for binding the LDL receptor, with potent anti-inflammatory and neuroprotective effects. COG 133 TFA is also a nAChR antagonist with an IC₅₀ of 445 nM .

HY-P2136F

Biotin-COG1410 TFA	Apoptosis	Neurological Disease Inflammation/Immunology Cancer
Biotin-COG1410 TFA is a biotin labled COG1410 (HY-P2136). COG1410 is an apolipoprotein E-derived peptide and an apoptosis inhibitor. COG1410 exerts neuroprotective and antiinflammatory effects in a murine model of traumatic brain injury (TBI). COG1410 can be used for the research of neurological disease .

HY-P10521

Apolipoprotein KV domain (67-77)	VEGFR	Cancer
Apolipoprotein KV domain (67-77) is an 11-amino acid peptide identified from the KV domain of human apolipoprotein a (ApoA) with antiangiogenic and antitumor activities. Apolipoprotein KV domain (67-77) targets the angiogenic c-Src/ERK pathway by blocking activation signals received from vascular endothelial growth factor (VEGF). Apolipoprotein KV domain (67-77) can be used in cancer research .

HY-P5169

LVGRQLEEFL (mouse)	Amino Acid Derivatives	Inflammation/Immunology
LVGRQLEEFL (mouse) can be named as G * peptide, corresponding to amino acids 113 to 122 in apolipoprotein J ([113,122] apoJ)}. LVGRQLEEFL (mouse) exhibits anti-inflammatory and anti-atherogenic properties. LVGRQLEEFL (mouse) can be added to an apoJ mimetic, to form HM-10/10 peptide, which is a mimetic peptide and a novel chimeric high density lipoprotein. HM-10/10 peptide protects retinal pigment epithelium (RPE) and photoreceptors from oxidant induced cell death .

HY-P5169A

LVGRQLEEFL (mouse) (TFA)	Amino Acid Derivatives	Inflammation/Immunology
LVGRQLEEFL (mouse) TFA can be named as G * peptide, corresponding to amino acids 113 to 122 in apolipoprotein J ([113,122] apoJ)}. LVGRQLEEFL (mouse) TFA exhibits anti-inflammatory and anti-atherogenic properties. LVGRQLEEFL (mouse) TFA can be added to an apoJ mimetic, to form HM-10/10 peptide, which is a mimetic peptide and a novel chimeric high density lipoprotein. HM-10/10 peptide protects retinal pigment epithelium (RPE) and photoreceptors from oxidant induced cell death .

HY-P10188

apoB (4372-4392)	Peptides	Cardiovascular Disease
apoB (4372-4392) is a potent lipoprotein(a) assembly inhibitor, with an IC₅₀ of 40 μM. apoB (4372-4392) can noncovalently bind to apolipoprotein(a) with high affinity .

HY-P10258

KRES peptide	Peptides	Cardiovascular Disease Inflammation/Immunology
KRES peptide is an apolipoprotein with 4 amino acid residues. KRES peptide interacts with lipids, reduces lipoprotein lipid hydroperoxides (LOOH), activates antioxidant enzymes associated with high-density lipoprotein. KRES peptide exhibits anti-inflammatory and anti-atherogenic properties. KRES peptide is orally active .

HY-P10453

Myr5A peptide	Peptides	Others
Myr5A peptide is an acylated peptide composed of apolipoprotein A1 (ApoA1) analog peptide 5A peptide coupled to the saturated fatty acid myristate. Myr5A peptide self-assembled into lipid nanostructures can be used to encapsulate anthracycline Doxorubicin (HY-15142A) and Valrubicin (HY-13772) for compound release studies in vitro .

HY-P10551

Apo A-I mimetic 5A peptide	Peptides	Cardiovascular Disease
Apo A-I mimetic 5A peptide is a synthetic peptide molecule designed based on the structure and function of naturally occurring apolipoprotein A-I (Apo A-I). Apo A-I mimetic 5A peptide can promote the efflux of cholesterol from cells and help reduce the accumulation of cholesterol in cells. Apo A-I mimetic 5A peptide also shows anti-inflammatory activity and can reduce inflammatory markers in blood and tissues. Apo A-I mimetic 5A peptide can be used in the study of cardiovascular diseases .

Cat. No.	Product Name	Category	Target	Chemical Structure

HY-A0143

Dihomo-γ-linolenic acid 3 Publications Verification DGLA; all-cis-8,11,14-Eicosatrienoic acid	Cardiovascular Disease Structural Classification Classification of Application Fields Ketones, Aldehydes, Acids Source classification Disease markers Endocrine diseases Endogenous metabolite Inflammation/Immunology Disease Research Fields	Endogenous Metabolite
Dihomo-γ-linolenic acid (DGLA) is a 20-carbon ω-6 fatty acid, with anti-inflammatory and anti-proliferative activities. Dihomo-γ-linolenic acid attenuates atherosclerosis in the apolipoprotein E deficient mouse model system .

HY-A0143A

Dihomo-γ-linolenic acid sodium DGLA sodium; all-cis-8,11,14-Eicosatrienoic acid sodium	Structural Classification Microorganisms Ketones, Aldehydes, Acids Source classification	Endogenous Metabolite
Dihomo-γ-linolenic acid (DGLA; all-cis-8,11,14-Eicosatrienoic acid) sodium is a 20-carbon ω-6 fatty acid, with anti-inflammatory and anti-proliferative activities. Dihomo-γ-linolenic acid (sodium) attenuates atherosclerosis in the apolipoprotein E deficient mouse model system .

Species:	Human (26) Mouse (13) Rat (2) Cynomolgus (1) Rabbit (2)
Tag:	SUMO (4) His (33) Tag Free (1) Myc (1) Fc (10) B2M (1)
Source:	HEK293 (30) P. pastoris (2) Sf9 insect cells (1) E. coli (11)

Cat. No.	Compare	Product Name	Species	Source

HY-P72082

	Apolipoprotein C-III/APOC3 Protein, Mouse (His-SUMO) Apoc3Apolipoprotein C-III; Apo-CIII; ApoC-III; Apolipoprotein C3	Mouse	E. coli
	Apolipoprotein C-III (APOC3) is a component of VLDL and HDL and plays a crucial role in triglyceride homeostasis. Intracellularly, it facilitates the assembly and secretion of VLDL1 for lipid transport. Apolipoprotein C-III/APOC3 Protein, Mouse (His-SUMO) is the recombinant mouse-derived Apolipoprotein C-III/APOC3 protein, expressed by E. coli , with N-6*His, N-SUMO labeled tag. The total length of Apolipoprotein C-III/APOC3 Protein, Mouse (His-SUMO) is 79 a.a., with molecular weight of ~24.9 kDa.

HY-P77872

	Apolipoprotein A-V/APOA5 Protein, Mouse (His) Apolipoprotein A-V; Apo-AV; ApoA-V; Apolipoprotein A5; Apoa5; Rap3	Mouse	E. coli
	Apolipoprotein AV (APOA5) is primarily associated with HDL and VLDL, affecting triglyceride (TG) levels. APOA5 stimulates apo-CII lipoprotein lipase (LPL) TG hydrolysis and inhibits hepatic VLDL-TG production without affecting VLDL-apoB production. Apolipoprotein A-V/APOA5 Protein, Mouse (His) is the recombinant mouse-derived Apolipoprotein A-V/APOA5 protein, expressed by E. coli , with N-His labeled tag. The total length of Apolipoprotein A-V/APOA5 Protein, Mouse (His) is 348 a.a., with molecular weight of ~40.5 kDa.

HY-P7532

	Apolipoprotein E/APOE Protein, Mouse (HEK293, His) rMuApolipoprotein E, His; ApoE; Apolipoprotein E	Mouse	HEK293
	Apolipoprotein E Protein, Mouse (HEK293, His) expresses in HEK293 with a His tag at the N-terminus. Apolipoprotein E regulates tight junction (TJs) function by regulating PKCη activity and phosphorylation of occludin on its Thr residues in an isoform-dependent manner. Apolipoprotein E also promotes cholesterol release.

HY-P7536

	Apolipoprotein M/APOM Protein, Human (HEK293, His) rHuApolipoprotein M, His; ApoM; Apolipoprotein M	Human	HEK293
	Apolipoprotein M Protein, Human (HEK293, His) expresses in HEK293 with a His tag at the N-terminus. Apolipoprotein E (apoE) secreted by HEK cells stably expressing apoE3 or apoE4 (HEK-apoE) binds Aβ, and inhibits Aβ-induced neurotoxicity . The signal peptide is not cleaved and is required for ApoM association with lipoprotein particles as well as Megalin mediated reabsorption by the kidney. ApoM is cleared from the circulation by the ubiquitously expressed LDL R.

HY-P7526

	Apolipoprotein A-I/APOA1 Protein, Human rHuApolipoprotein A-I; ApoA1; Apolipoprotein A-I	Human	E. coli
	Apolipoprotein A-I/APOA1 Protein is a secreted protein located on the outside of cell membranes and is the main structural apolipoprotein of high-density lipoprotein (HDL), playing a key role in the reverse cholesterol transport pathway. Apolipoprotein A-I/APOA1 protein interacts with the cell surface receptor SR-BI, thereby promoting dengue virus (DV) infection. Apolipoprotein A-I/APOA1 Protein can also activate sperm motility as part of the SPAP complex. Apolipoprotein A-I/APOA1 Protein has anti-inflammatory, anti-atherosclerotic, anti-apoptotic, anti-tumor, and anti-thrombotic functions. Apolipoprotein A-I/APOA1 Protein Protein, Human is made up of 267 amino acids and is expressed in Escherichia coli (E. coli).

HY-P72297

	Apolipoprotein M/APOM Protein, Mouse (P.pastoris, His) Apom; Ng20Apolipoprotein M; Apo-M	Mouse	P. pastoris
	Apolipoprotein M (APOM) is likely involved in lipid transport, binding various molecules, including sphingosine-1-phosphate, myristic acid, palmitic acid, stearic acid, retinol, all-trans-retinoic acid, and 9-cis-retinoic acid. Interacting with LRP2, APOM undergoes renal uptake facilitated by LRP2, followed by lysosomal degradation. This suggests APOM's role in mediating dynamic lipid and retinoid metabolism processes within the body. Apolipoprotein M/APOM Protein, Mouse (P.pastoris, His) is the recombinant mouse-derived Apolipoprotein M/APOM, expressed by P. pastoris , with N-His labeled tag.

HY-P78239

	Apolipoprotein E/APOE Protein, Mouse (HEK293, Fc) Apolipoprotein E; Apo-E; APOE; apolipo E	Mouse	HEK293
	Apolipoprotein E/APOE is crucial in lipid transport and participates in the production, transformation and clearance of plasma lipoproteins. It interacts with various particles, including chylomicrons and high-density lipoproteins, and binds to cellular receptors such as LDLR and VLDLR, promoting uptake. Apolipoprotein E/APOE Protein, Mouse (HEK293, Fc) is the recombinant mouse-derived Apolipoprotein E/APOE protein, expressed by HEK293 , with C-hFc labeled tag. The total length of Apolipoprotein E/APOE Protein, Mouse (HEK293, Fc) is 293 a.a., with molecular weight of 62-66 kDa.

HY-P7531

	Apolipoprotein E/APOE3 Protein, Human (HEK293, His) rHuApolipoprotein E, His; ApoE; Apolipoprotein E; APOE3	Human	HEK293
	Apolipoprotein E/ApoE3 is an apolipoprotein isoform that mediates lipid transport and plays a crucial role in lipid homeostasis in both plasma and the central nervous system by binding to LDL receptors (LDLR), LDL receptor-related proteins (LRP1, LRP2, LRP8), Very Low-Density Lipoprotein Receptor (VLDLR), and Heparin. The Apolipoprotein E/ApoE3 Protein, Human (HEK293, His) is a recombinant protein with a His tag at the N-terminus, consisting of 299 amino acids (K19-H317), and is expressed in HEK293 cells.

HY-P7536A

	Apolipoprotein M/APOM Protein, Human (166a.a, HEK293, His) rHuApolipoprotein M, His; ApoM; Apolipoprotein M	Human	HEK293
	Apolipoprotein M Protein, Human (166a.a, HEK293, His) expresses in HEK293, does not contain signal peptide sequence with a His tag at the N-terminus. Apolipoprotein E (apoE) secreted by HEK cells stably expressing apoE3 or apoE4 (HEK-apoE) binds Aβ, and inhibits Aβ-induced neurotoxicity .

HY-P77562

	Apolipoprotein A-II/APOA2 Protein, Mouse (HEK293, Fc) Apolipoprotein A-II; Apo-AII; Apolipoprotein A2; ProapoA-II; Apolipoprotein A-II(1-76); APOA2	Mouse	HEK293
	Apolipoprotein A-II/APOA2 protein may stabilize high-density lipoprotein (HDL) structure and affect HDL metabolism through lipid association. As a monomer, APOA2 is critical for maintaining HDL integrity and function. Apolipoprotein A-II/APOA2 Protein, Mouse (HEK293, Fc) is the recombinant mouse-derived Apolipoprotein A-II/APOA2 protein, expressed by HEK293 , with C-hFc labeled tag. The total length of Apolipoprotein A-II/APOA2 Protein, Mouse (HEK293, Fc) is 84 a.a., with molecular weight of 40-45 kDa.

HY-P700853

	Apolipoprotein E/APOE4 Protein, Human (HEK293, His) Apolipoprotein E; Apo-E; APOE; apolipo E; APOE4	Human	HEK293

HY-P701051

	Apolipoprotein E/APOE3 Protein, Human (HEK293, hFc) Apolipoprotein E; Apo-E; APOE; apolipo E; APOE3	Human	HEK293
	Apolipoprotein E (APOE) plays a key role in lipoprotein-mediated lipid transport and is a core component in the production, transformation, and clearance of plasma lipoproteins. As an amphipathic molecule, APOE binds to various lipoprotein particles, including chylomicrons, chylomicron remnants, VLDL, and IDL, favoring HDL. Apolipoprotein E/APOE3 Protein, Human (HEK293, hFc) is the recombinant human-derived Apolipoprotein E/APOE3 protein, expressed by HEK293 , with N-hFc labeled tag. The total length of Apolipoprotein E/APOE3 Protein, Human (HEK293, hFc) is 299 a.a., with molecular weight of 60-70 kDa.

HY-P7525

	Apolipoprotein A-I/APOA1 Protein, Human (HEK293, His) 1 Publications Verification rHuApolipoprotein A-I, His; ApoA1; Apolipoprotein A-I	Human	HEK293
	Apolipoprotein A-I Protein, Human (HEK293, His) expresses in HEK293 with a His tag at the N-terminus. Apolipoprotein A-I (ApoA-I), the major protein component in high-density lipoprotein (HDL), plays key roles in the Reverse Cholesterol Transport pathway. Apolipoprotein A-I is associated with dengue virus (DV) particles and enhances virus infection through SR-BI.

HY-P7527

	Apolipoprotein A-II/APOA2 Protein, Human (HEK293, His) rHuApolipoprotein A-II, His; ApoA2; Apolipoprotein A-II	Human	HEK293
	Apolipoprotein A-II/ApoA2 Protein, Human (HEK293, His) expresses in HEK293 with a His tag at the N-terminus. Apolipoprotein A-II (ApoA-II) has been associated with numerous aspects of HDL metabolism, and apoA-II overexpression produces the proatherogenic phenotype.

HY-P72832

	Apolipoprotein A-I/APOA1 Protein, Human (HEK293, Fc) Apolipoprotein A-I; Apo-AI; ProapoA-I; APOA1	Human	HEK293
	Apolipoprotein AI plays a key role in reverse cholesterol transport, promoting cholesterol efflux from tissues and acting as a cofactor for lecithin cholesterol acyltransferase (LCAT). It forms homodimers and participates in the SPAP complex, which is essential for sperm motility, interacting with both NAXE and CLU. Apolipoprotein A-I/APOA1 Protein, Human (HEK293, Fc) is the recombinant human-derived Apolipoprotein A-I/APOA1 protein, expressed by HEK293 , with C-hFc labeled tag.

HY-P74410

	Apolipoprotein H/APOH Protein, Rat (HEK293, His) Apolipoprotein H; ApoH; B2G1; B2GP1	Rat	HEK293
	Apolipoprotein H/APOH proteins have multiple functions and can bind to negatively charged substances such as heparin and phospholipids. Its diverse interactions highlight the adaptability that is critical for preventing activation of the intrinsic coagulation cascade by binding to phospholipids on the surface of damaged cells. Apolipoprotein H/APOH Protein, Rat (HEK293, His) is the recombinant rat-derived Apolipoprotein H/APOH protein, expressed by HEK293 , with C-His labeled tag.

HY-P75504

	Apolipoprotein L/APOL1 Protein, Human (sf9, His) Apolipoprotein L1; Apo-L; ApoL-I; APOL1; APOL	Human	Sf9 insect cells
	Apolipoprotein L (APOL1) Protein is a member of the apolipoprotein L family. Apolipoprotein L/APOL1 Protein, Human (sf9, His) is the recombinant human-derived Apolipoprotein L/APOL1 protein, expressed by Sf9 insect cells , with C-His labeled tag. The total length of Apolipoprotein L/APOL1 Protein, Human (sf9, His) is 371 a.a., with molecular weight of ~44 kDa.

HY-P78062

	Apolipoprotein E/APOE3 Protein, Human (Biotinylated, HEK293, His) Apolipoprotein E; Apo-E; APOE; apolipo E; APOE3	Human	HEK293
	Apolipoprotein E (APOE) plays a key role in lipoprotein-mediated lipid transport and is a core component in the production, transformation, and clearance of plasma lipoproteins. As an amphipathic molecule, APOE binds to various lipoprotein particles, including chylomicrons, chylomicron remnants, VLDL, and IDL, favoring HDL. Apolipoprotein E/APOE Protein, Human (Biotinylated, HEK293, His) is the recombinant human-derived Apolipoprotein E/APOE protein, expressed by HEK293 , with N-His labeled tag. The total length of Apolipoprotein E/APOE Protein, Human (Biotinylated, HEK293, His) is 299 a.a., with molecular weight of 35-40 kDa.

HY-P75503A

	Apolipoprotein A-I/APOA1 Protein, Mouse (HEK293, His) Apolipoprotein L1; Apo-L; ApoL-I; APOL1; APOL	Mouse	HEK293
	The apolipoprotein AI (APOA1) protein is key to reverse cholesterol transport, promoting tissue efflux, and serves as an important cofactor for lecithin cholesterol acyltransferase (LCAT), promoting cholesterol excretion. As a homodimer, APOA1 is a component of the sperm activating protein complex (SPAP), interacts with APOA1BP, CLU, NDRG1, SCGB3A2, NAXE and YJEFN3, exhibiting multiple molecular associations. Apolipoprotein A-I/APOA1 Protein, Mouse (HEK293, His) is the recombinant mouse-derived Apolipoprotein A-I/APOA1 protein, expressed by HEK293 , with C-6*His labeled tag.

HY-P75503

	Apolipoprotein A-I/APOA1 Protein, Mouse (HEK293, His, solution) Apolipoprotein L1; Apo-L; ApoL-I; APOL1; APOL	Mouse	HEK293
	The apolipoprotein AI (APOA1) protein is key to reverse cholesterol transport, promoting tissue efflux, and serves as an important cofactor for lecithin cholesterol acyltransferase (LCAT), promoting cholesterol excretion. As a homodimer, APOA1 is a component of the sperm activating protein complex (SPAP), interacts with APOA1BP, CLU, NDRG1, SCGB3A2, NAXE and YJEFN3, exhibiting multiple molecular associations. Apolipoprotein A-I/APOA1 Protein, Mouse (HEK293, His, solution) is the recombinant mouse-derived Apolipoprotein A-I/APOA1 protein, expressed by HEK293 , with C-His labeled tag.

HY-P78542A

	Apolipoprotein E/APOE4 Protein, Human (C130R, HEK293, Fc) Apolipoprotein E; Apo-E; APOE; apolipo E; APOE4	Human	HEK293
	Apolipoprotein E (APOE) plays a key role in lipoprotein-mediated lipid transport and is a core component in the production, transformation, and clearance of plasma lipoproteins. As an amphipathic molecule, APOE binds to various lipoprotein particles, including chylomicrons, chylomicron remnants, VLDL, and IDL, favoring HDL. Apolipoprotein E/APOE Protein, Human (C130R, HEK293, Fc) is the recombinant human-derived Apolipoprotein E/APOE protein, expressed by HEK293 , with N-hFc labeled tag and C130R, , , , mutation. The total length of Apolipoprotein E/APOE4 Protein, Human (C130R, HEK293, Fc) is 299 a.a., with molecular weight (glycosylation form) of 63-68 kDa.

HY-P7533

	Apolipoprotein H/APOH Protein, Human (HEK293, His) rHuApolipoprotein H, His; ApoH; B2G1; B2GP1; Apolipoprotein H	Human	HEK293
	Apolipoprotein H Protein, Human (HEK293, His) expresses in HEK293 with a His tag at the N-terminus. Apolipoprotein H (ApoH) is the main target of anti-phospholipid antibodies (aPLs) found in many patients with systemic lupus erythematosus and antiphospholipid syndrome (APS).

HY-P72833

	Apolipoprotein A-I/APOA1 Protein, Mouse (246a.a, HEK293, Fc) Apolipoprotein A-I; Apo-AI; ProapoA-I; APOA1	Mouse	HEK293
	The apolipoprotein AI (APOA1) protein is key to reverse cholesterol transport, promoting tissue efflux, and serves as an important cofactor for lecithin cholesterol acyltransferase (LCAT), promoting cholesterol excretion. As a homodimer, APOA1 is a component of the sperm activating protein complex (SPAP), interacts with APOA1BP, CLU, NDRG1, SCGB3A2, NAXE and YJEFN3, exhibiting multiple molecular associations. Apolipoprotein A-I/APOA1 Protein, Mouse (246a.a, HEK293, Fc) is the recombinant mouse-derived Apolipoprotein A-I/APOA1 protein, expressed by HEK293 , with C-hFc labeled tag. The total length of Apolipoprotein A-I/APOA1 Protein, Mouse (246a.a, HEK293, Fc) is 246 a.a., with molecular weight of ~58 kDa.

HY-P78542

	Apolipoprotein E/APOE4 Protein, Human (C130R, HEK293, Fc, solution) Apolipoprotein E; Apo-E; APOE; apolipo E; APOE4	Human	HEK293
	Apolipoprotein E (APOE) plays a key role in lipoprotein-mediated lipid transport and is a core component in the production, transformation, and clearance of plasma lipoproteins. As an amphipathic molecule, APOE binds to various lipoprotein particles, including chylomicrons, chylomicron remnants, VLDL, and IDL, favoring HDL. Apolipoprotein E/APOE Protein, Human (C130R, HEK293, Fc) is the recombinant human-derived Apolipoprotein E/APOE protein, expressed by HEK293 , with N-hFc labeled tag and C130R, , , , mutation. The total length of Apolipoprotein E/APOE Protein, Human (C130R, HEK293, Fc) is 299 a.a., with molecular weight (glycosylation form) of 63-67 kDa.

HY-P7534A

	Apolipoprotein H/APOH Protein, Mouse (HEK293, His) rMuApolipoprotein H, His; ApoH; B2G1; B2GP1; Apolipoprotein H	Mouse	HEK293
	Apolipoprotein H/APOH protein binds to heparin, phospholipids, and dextran sulfate, preventing activation of the blood coagulation cascade by interacting with phospholipids on damaged cell surfaces. Apolipoprotein H/APOH Protein, Mouse (HEK293, His) is the recombinant mouse-derived Apolipoprotein H/APOH protein, expressed by HEK293 , with C-His labeled tag.

HY-P701094

	Apolipoprotein E/APOE2 Protein, Human (R154S, R176C, HEK293, C-His) Apolipoprotein E; APOE; Apo-E; APOE2	Human	HEK293
	Apolipoprotein E (APOE) plays a key role in lipoprotein-mediated lipid transport and is a core component in the production, transformation, and clearance of plasma lipoproteins. As an amphipathic molecule, APOE binds to various lipoprotein particles, including chylomicrons, chylomicron remnants, VLDL, and IDL, favoring HDL. Apolipoprotein E/APOE Protein, Human (R154S, R176C, HEK293, C-His) is the recombinant human-derived Apolipoprotein E/APOE protein, expressed by HEK293 , with C-6*His labeled tag and R154S, R176C, , , mutation. The total length of Apolipoprotein E/APOE Protein, Human (R154S, R176C, HEK293, C-His) is 299 a.a., with molecular weight of 33-42 kDa.

HY-P7524A

	Apolipoprotein B-100/APOB Protein, Human (His) APOB; ApolipoproteinB-100	Human	E. coli
	Apolipoprotein B-100 (APOB) is a key component of chylomicrons, LDL and VLDL. It acts as a recognition signal to promote cellular binding and internalization of LDL through apoB/E receptors. Apolipoprotein B-100/APOB Protein, Human (His) is the recombinant human-derived Apolipoprotein B-100/APOB protein, expressed by E. coli , with N-6*His labeled tag. The total length of Apolipoprotein B-100/APOB Protein, Human (His) is 100 a.a., with molecular weight of ~16.0 kDa.

HY-P701096

	Apolipoprotein E/APOE Protein, Rat (His) APOEApolipoprotein E; Apo-E	Rat	E. coli
	Apolipoprotein E/APOE is essential for lipid transport and is integral to the production, transformation and clearance of plasma lipoproteins.It interacts with various particles to favor HDL and binds to receptors such as LDLR and VLDLR to promote cellular uptake.Apolipoprotein E/APOE Protein, Rat (His) is the recombinant rat-derived Apolipoprotein E/APOE protein, expressed by E.coli , with N-6*His labeled tag.

HY-P72083

	Apolipoprotein E/APOE Protein, Rabbit (His-SUMO) APOEApolipoprotein E; Apo-E	Rabbit	E. coli
	Apolipoprotein E/APOE is essential for lipid transport between organs and is a key component of lipoproteins such as chylomicrons and high-density lipoprotein. It binds to cell receptors such as LDLR and VLDLR to promote lipoprotein uptake, and has heparin-binding activity to interact with cell surface proteoglycans. Apolipoprotein E/APOE Protein, Rabbit (His-SUMO) is the recombinant Rabbit-derived Apolipoprotein E/APOE protein, expressed by E. coli , with N-10*His, N-SUMO labeled tag. The total length of Apolipoprotein E/APOE Protein, Rabbit (His-SUMO) is 292 a.a., with molecular weight of ~53.6 kDa.

HY-P7524

	Apolipoprotein B-100/APOB Protein, Human (His, solution) rHuApolipoproteinB-100, His; APOB; ApolipoproteinB-100	Human	E. coli
	Apolipoprotein B-100/Apo B Protein, Human (His, solution) expresses in E. coli with a His tag at the N-terminus. Human Apolipoprotein B-100 (apo B-100) is the major apolipoprotein of low density lipoproteins and the principal ligand for interaction with the low density lipoprotein receptor.

HY-P72084

	Apolipoprotein E/APOE Protein, Rabbit (His-B2M, Myc) APOEApolipoprotein E; Apo-E	Rabbit	E. coli
	Apolipoprotein E/APOE is essential for lipid transport between organs and is a key component of lipoproteins such as chylomicrons and high-density lipoprotein. It binds to cell receptors such as LDLR and VLDLR to promote lipoprotein uptake, and has heparin-binding activity to interact with cell surface proteoglycans. Apolipoprotein E/APOE Protein, Rabbit (His-B2M, Myc) is the recombinant Rabbit-derived Apolipoprotein E/APOE protein, expressed by E. coli , with N-10*His, C-Myc, N-B2M labeled tag. The total length of Apolipoprotein E/APOE Protein, Rabbit (His-B2M, Myc) is 292 a.a., with molecular weight of ~55 kDa.

HY-P78238

	Apolipoprotein A-I/APOA1 Protein, Mouse (240a.a, HEK293, Fc) Apo-AI; ProapoA-I; Apoa1; Apolipoprotein A-I; APOA1; MGC117399; Alp-1; Brp-14; Ltw-1; Lvtw-1; Sep-1; Sep-2	Mouse	HEK293
	Apolipoprotein A-I (APOA1) Protein, pivotal in cholesterol reverse transport, facilitates efflux from tissues and acts as a crucial cofactor for lecithin cholesterol acyltransferase (LCAT), promoting cholesterol excretion. As a homodimer, APOA1 is integral to the sperm activating protein complex (SPAP), interacting with APOA1BP, CLU, NDRG1, SCGB3A2, NAXE, and YJEFN3, demonstrating diverse molecular associations. Its involvement extends beyond cholesterol metabolism to influence cellular processes like spermatozoa motility and protein interactions. Apolipoprotein A-I/APOA1 Protein, Mouse (240a.a, HEK293, Fc) is the recombinant mouse-derived Apolipoprotein A-I/APOA1 protein, expressed by HEK293, with C-hFc labeled tag. The total length of Apolipoprotein A-I/APOA1 Protein, Mouse (240a.a, HEK293, Fc) is 240 a.a., with molecular weight of 55-65 kDa.

HY-P700660

	Apolipoprotein H/APOH Protein, Cynomolgus (HEK293, His) Apo-H; B2GP1; B2G1; APOH; B2GPI; beta(2)GPI; BG; β(2)GPI;	Cynomolgus	HEK293
	Apolipoprotein H/APOH proteins have multiple functions and can bind to negatively charged substances such as heparin and phospholipids. Its diverse interactions highlight the adaptability that is critical for preventing activation of the intrinsic coagulation cascade by binding to phospholipids on the surface of damaged cells. Apolipoprotein H/APOH Protein, Cynomolgus (HEK293, His) is the recombinant cynomolgus-derived Apolipoprotein H/APOH protein, expressed by HEK293 , with C-His labeled tag. The total length of Apolipoprotein H/APOH Protein, Cynomolgus (HEK293, His) is 326 a.a., with molecular weight of 50-65 kDa.

HY-P71715

	*ApoA-IV Protein, Mouse (P.pastoris, His)* Apoa4; Apolipoprotein A-IV; Apo-AIV; ApoA-IV; Apolipoprotein A4	Mouse	P. pastoris
	ApoA-IV Protein plays a vital role in lipid metabolism, influencing chylomicron and VLDL secretion and catabolism. It efficiently activates lipoprotein lipase with ApoC-II and serves as a potent activator of LCAT. As a component of HDL and chylomicrons, ApoA-IV is integral to cholesterol transport and metabolism. Structurally, the protein forms homodimers, reflecting its crucial role in lipid-related processes. ApoA-IV Protein, Mouse (P.pastoris, His) is the recombinant mouse-derived ApoA-IV protein, expressed by P. pastoris , with N-6*His labeled tag. The total length of ApoA-IV Protein, Mouse (P.pastoris, His) is 375 a.a., with molecular weight of ~45.0 kDa.

HY-P72081

	*APOC3 Protein, Human (His-SUMO)* APOC3; APO C3; Apo CIII; Apo-CIII; APOC 3; ApoC III; ApoC-III; APOC3; APOC3_HUMAN; ApoCIII; Apolipoprotein C III; Apolipoprotein C-III; Apolipoprotein C3; ApolipoproteinCIII; MGC150353	Human	E. coli
	APOC3 protein is found in VLDL and HDL and plays a crucial role in triglyceride homeostasis. Intracellularly, it facilitates VLDL1 assembly and secretion and assists in lipid transport. APOC3 Protein, Human (His-SUMO) is the recombinant human-derived APOC3 protein, expressed by E. coli , with N-6*His, N-SUMO labeled tag. The total length of APOC3 Protein, Human (His-SUMO) is 79 a.a., with molecular weight of ~24.8 kDa.

HY-P7530A

	*APOD Protein, Human (HEK293, C-His)* rHuApolipoprotein D, His; ApoD; Apolipoprotein D	Human	HEK293
	APOD Proteinas is an anti-inflammatory antagonist in the IL-1 family, targeting IL1B and IL1A to prevent immune dysregulation and systemic inflammation. Its ability to modulate inflammatory responses has important implications for potential therapeutic intervention in inflammatory diseases. APOD Protein, Human (HEK293, C-His) is the recombinant human-derived APOD protein, expressed by HEK293 , with C-10*His labeled tag. The total length of APOD Protein, Human (HEK293, C-His) is 169 a.a., with molecular weight of 25-40 kDa.

HY-P7529

	*APOC2 Protein, Human (His)* rHuApolipoprotein C-II, His; ApoC2; Apolipoprotein C-II	Human	E. coli
	Apolipoprotein C-II Protein, Human (His) is expressed in E. coli with a His tag at the N-terminus. Apolipoprotein C-II Protein, Human (His) has a pharmacological application for the treatment of patients with genetic hypertriglyceridemia caused by ApoC-II otein C-II Protein, Human (His) is expressed in E. coli with a His tag at the C-terminus. Apolipoprotein C-II Protein, Human (His) has a pharmacological application for the treatment of patients with genetic hypertriglyceridemia caused by ApoC-II deficiency.

HY-P7528

	*ApoA-IV Protein, Human (HEK293, His)* rHuApolipoprotein A-IV, His; ApoA4; Apolipoprotein A-IV	Human	HEK293
	ApoA-IV Protein, Human (HEK293, His) expresses in HEK293 with a His tag at the N-terminus. Apolipoprotein A-IV (Apo A-IV) has a role in reverse cholesterol transport.

HY-P70058

	*Clusterin/APOJ Protein, Mouse (HEK293, His)* rMuClusterin/CLU, His ; Clusterin; Apolipoprotein J; Clustrin; Sulfated glycoprotein 2	Mouse	HEK293
	Clusterin/APOJ proteins act as extracellular chaperones, inhibiting stress-induced plasma protein aggregation and preventing the formation of amyloid fibrils by various proteins. It maintains partially unfolded proteins in a proper state for refolding by other partners. Clusterin/APOJ Protein, Mouse (HEK293, His) is the recombinant mouse-derived Clusterin/APOJ protein, expressed by HEK293 , with C-6*His labeled tag. The total length of Clusterin/APOJ Protein, Mouse (HEK293, His) is 427 a.a., with molecular weight of (29-43) & 67 kDa, respectively.

HY-P7535

	*Clusterin/APOJ Protein, Human (HEK293, Fc-His)* rHuApolipoprotein J, C-Fc-His; ApoJ; Clusterin; CLU; CLI; KUB1; Apolipoprotein J	Human	HEK293
	Clusterin/APOJ Protein, Human (HEK293, Fc-His) expresses in HEK293 with an Fc fragment and a His tag at the N-terminus. Apolipoprotein J (ApoJ) is involved in numerous physiological process important for lipid transportation, vascular smooth muscle cell differentiation, and has the potential for atherosclerosis.

HY-P76155

	*APOA1BP Protein, Human (HEK293, His)* NAD(P)H-hydrate epimerase; Apolipoprotein A-I-binding protein; AI-BP; YJEFN1; NAXE; AIBP	Human	HEK293
	APOA1BP protein plays a crucial role in cellular processes by catalyzing the S- and R-type epimerization of NAD(P)HX, a protein that results from enzymatic or heat-dependent hydration. Damaged form of NAD(P)H. This catalytic activity is a prerequisite for the subsequent action of S-specific NAD(P)H hydrate dehydratase, enabling the repair of both epimers of NAD(P)HX. APOA1BP Protein, Human (HEK293, His) is the recombinant human-derived APOA1BP protein, expressed by HEK293 , with C-His labeled tag.

HY-P77066

	*LPAL2 Protein, Human (HEK293, Fc)* Putative Apolipoprotein(a)-like protein 2; Apo(a)-like protein 2; APOARGC	Human	HEK293
	LPAL2 is a pseudogene and modulates tumor growth, metastasis and stemness phenotypes of HCC. LPAL2 is a biomarker in malignant cholangiocytes. LPAL2/miR-1287-5p axis modulates TGF-β1–induced increases in cell adhesion factor levels and thyroid eye disease (TED) orbital fibroblast activation through EGFR/AKT signaling. LPAL2 Protein, Human (HEK293, Fc) is the recombinant human-derived LPAL2 protein, expressed by HEK293 , with C-mFc labeled tag.

HY-P72080

	*APOBEC3A Protein, Human (His-SUMO)* A3A; ABC3A_HUMAN; APOBEC3A; Apolipoprotein B mRNA editing enzyme; Apolipoprotein B mRNA editing enzyme; catalytic polypeptide like 3A; ARP3; bK150C2.1; Catalytic polypeptide like 3A; Phorbolin 1; Phorbolin-1; PHRBN; Probable DNA dC >dU editing enzyme APOBEC-3A; Probable DNA dC->dU-editing enzyme APOBEC-3A	Human	E. coli
	APOBEC3A protein is a DNA deaminase that limits the mobility of viruses, foreign DNA, and retrotransposons. APOBEC3A Protein, Human (His-SUMO) is the recombinant human-derived APOBEC3A protein, expressed by E. coli , with N-6*His, N-SUMO labeled tag.

HY-P7895

	*Clusterin/APOJ Protein, Human (HEK293, His)* rHuClusterin/APOJ, His ; Clusterin; Aging-Associated Gene 4 Protein; Apolipoprotein J; Apo-J; Complement Cytolysis Inhibitor; CLI; Complement-Associated Protein SP-40; Ku70-Binding Protein 1; NA1/NA2; Testosterone-Repressed Prostate Message 2; TRPM-2; CLU; APOJ; CLI; KUB1	Human	HEK293
	Clusterin/APOJ Protein, Human (HEK 293, His) expresses in HEK 293 cells with a His tag at the C-terminus. Clusterin (CLU) is a multifunctional glycoprotein that has been implicated in several physiological and pathological states, including Alzheimer’s disease (AD).

Compare Products


Products	In-stock - + Add to Cart
Cat. No.
Species
Source
Tag
Accession
Gene ID
Molecular Weight
Purity
Endotoxin Level
Biological Activity
Appearance
Formulation
Storage & Stability
Shipping
Free Sample	Yes No
Size	* This product has been "discontinued". Optimized version of product available: / In-stock - + Add to Cart Get quote

Cat. No.	Product Name	Chemical Structure

HY-A0143S

Dihomo-γ-linolenic acid-d6
Dihomo-γ-linolenic acid-d₆ (DGLA-d₆) is the deuterium labeled Dihomo-γ-linolenic acid. Dihomo-γ-linolenic acid (all-cis-8,11,14-Eicosatrienoic acid) is a 20-carbon ω-6 fatty acid, with anti-inflammatory and anti-proliferative activities. Dihomo-γ-linolenic acid attenuates atherosclerosis in the apolipoprotein E deficient mouse model system[1][2][3].

Cat. No.	Compare	Product Name	Application	Reactivity

HY-P81137

	APOA1 Antibody Apo-AI; ApoA I; ApoA-I; APOA1_HUMAN; Apolipoprotein A-I(1-242); Apolipoprotein A1; Apolipoprotein A 1; Apolipoprotein AI; Apolipoprotein A I; Brp14; Ltw1; Lvtw1; Sep1; Sep2.	WB, IHC-P, ICC/IF, IP	Human, Mouse
	APOA1 Antibody is an unconjugated, approximately 31 kDa, rabbit-derived, anti-APOA1 monoclonal antibody. APOA1 Antibody can be used for: WB,IHC-P,ICC/IF,IP expriments in human, mouse background without labeling.

HY-P81771

	ApoE Antibody (YA1516) APOE; Apolipoprotein E; Apo-E	WB, IHC-P, ICC/IF, IP	Human, Mouse
	ApoE Antibody (YA1516) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA1516), targeting ApoE, with a predicted molecular weight of 36 kDa. ApoE Antibody (YA1516) can be used for WB, IHC-P, ICC/IF, IP experiment in human, mouse background.

HY-P82821

	ApoB Antibody (YA2566) APOB; Apolipoprotein B-100; Apo B-100	WB, IP, FC	Human
	ApoB Antibody (YA2566) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA2566), targeting ApoB, with a predicted molecular weight of 516 kDa (observed band size: 516 kDa). ApoB Antibody (YA2566) can be used for WB, IP, FC experiment in human background.

HY-P82148

	ApoL1 Antibody (YA1893) APOL1; APOL; Apolipoprotein L1; Apolipoprotein L; Apo-L; ApoL; Apolipoprotein L-I; ApoL-I	WB, ICC/IF, IP, FC	Human
	ApoL1 Antibody (YA1893) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA1893), targeting ApoL1, with a predicted molecular weight of 44 kDa (observed band size: 44 kDa). ApoL1 Antibody (YA1893) can be used for WB, ICC/IF, IP, FC experiment in human background.

HY-P82458

	ApoF Antibody (YA2203) Apof; Apolipoprotein F; LTIP	WB, ICC/IF	Human
	ApoF Antibody (YA2203) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA2203), targeting ApoF, with a predicted molecular weight of 35 kDa (observed band size: 35 kDa). ApoF Antibody (YA2203) can be used for WB, ICC/IF experiment in human background.

HY-P82847

	ApoA4 Antibody (YA2592) Apo AIV; APOA 4; ApoA IV; APOA4; Apolipoprotein A IV; Apolipoprotein A4	WB, IP	Human
	ApoA4 Antibody (YA2592) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA2592), targeting ApoA4, with a predicted molecular weight of 45 kDa (observed band size: 45 kDa). ApoA4 Antibody (YA2592) can be used for WB, IP experiment in human background.

HY-P83604

	ApoC3 Antibody (YA3349) APOC3; APO C3; Apo CIII; ApoC III; APOC3; ApoCIII; Apolipoprotein C III; Apolipoprotein C3	WB, IHC-P	Human
	ApoC3 Antibody (YA3349) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA3349), targeting ApoC3, with a predicted molecular weight of 11 kDa (observed band size: 11 kDa). ApoC3 Antibody (YA3349) can be used for WB, IHC-P experiment in human background.

HY-P82987

	ApoA Antibody (YA2732) LPA; Apolipoprotein(a; Apo(a); Lp(a)	WB	Human
	ApoA Antibody (YA2732) is a biotin-conjugated non-conjugated IgG antibody, targeting ApoA, with a predicted molecular weight of 227 kDa (observed band size: 501 kDa). ApoA Antibody (YA2732) can be used for WB experiment in human background.

HY-P82297

	ApoH Antibody (YA2042) APC inhibitor; APOH; Apolipoprotein H; B2G1; B2GP1; B2GPI; BG	WB, ICC/IF, IP	Human, Rat
	ApoH Antibody (YA2042) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA2042), targeting ApoH, with a predicted molecular weight of 38 kDa (observed band size: 55 kDa). ApoH Antibody (YA2042) can be used for WB, ICC/IF, IP experiment in human, rat background.

HY-P82835

	ApoM Antibody (YA2580) APOM; G3A; NG20; HSPC336; Apolipoprotein M; Apo-M; ApoM; Protein G3a	WB, IHC-P, FC	Human
	ApoM Antibody (YA2580) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA2580), targeting ApoM, with a predicted molecular weight of 21 kDa (observed band size: 25 kDa). ApoM Antibody (YA2580) can be used for WB, IHC-P, FC experiment in human background.

HY-P81714

	ApoA2 Antibody (YA1459) APO A2; Apo AII; APOA 2; ApoA II; APOA2; APOAII; Apolipoprotein A II	WB, ICC/IF, FC	Human, Rat
	ApoA2 Antibody (YA1459) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA1459), targeting ApoA2, with a predicted molecular weight of 11 kDa (observed band size: 11 kDa). ApoA2 Antibody (YA1459) can be used for WB, ICC/IF, FC experiment in human, rat background.

HY-P82383

	ApoER2 Antibody (YA2128) LRP8; APOER2; Low-density lipoprotein receptor-related protein 8; LRP-8; Apolipoprotein E receptor 2	WB, IP	Human, Rat, Hamster
	ApoER2 Antibody (YA2128) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA2128), targeting ApoER2, with a predicted molecular weight of 106 kDa (observed band size: 130,106 kDa). ApoER2 Antibody (YA2128) can be used for WB, IP experiment in human, rat, hamster background.

HY-P81478

	NR2F2 Antibody (YA1223) NR2F2; ARP1; TFCOUP2; COUP transcription factor 2; COUP-TF2; Apolipoprotein A-I regulatory protein 1; ARP-1; COUP transcription factor II; COUP-TF II; Nuclear receptor subfamily 2 group F member 2	IHC-P	Human
	NR2F2 Antibody (YA1223) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA1223), targeting NR2F2. NR2F2 Antibody (YA1223) can be used for IHC-P experiment in human background.

Compare Products


Products	In-stock - + Add to Cart
Cat. No.
Host
Reactivity
Application
Dilution Ratio
Molecular Weight
Conjugation
Clonality
Immunogen
Appearance
Isotype
Gene ID
SwissProt ID
Purity
Formulation
Free Sample	Yes No
Size	* This product has been "discontinued". Optimized version of product available: / In-stock - + Add to Cart Get quote

Cat. No.	Product Name		Classification

HY-147425A

Zerlasiran sodium SLN360 sodium		siRNAs
Zerlasiran sodium is an apolipoprotein A (ApoA) synthesis reducer .

HY-151123A

Pelacarsen sodium AKCEA-APO(a)-LRx sodium; ISIS 681257 sodium; TQJ230 sodium		Antisense Oligonucleotides
Pelacarsen sodium is a liver-specific antisense oligonucleotide against *apolipoprotein(a)* that reduces lipoprotein(a) up to 80% with good tolerability .

HY-145727A

Volanesorsen sodium ISIS 304801 sodium		Antisense Oligonucleotides
Volanesorsen sodium is an antisense oligonucleotide thay targes Apolipoprotein C-III (APOC3) mRNA. Volanesorsen sodium is used for the study of familial chylomicronemia syndrome.

HY-108764

Mipomersen sodium ISIS 301012		Antisense Oligonucleotides
Mipomersen sodium (ISIS 301012) is an antisense oligonucleotide inhibitor of apolipoprotein B (apoB). Mipomersen has anti-HCV effect and reduces the infectivity of the HCV. Mipomersen sodium can be used for the research of homozygous familial hypercholesterolemia (HoFH) .

HY-147425

Zerlasiran SLN360		siRNAs
Zerlasiran is an apolipoprotein A (ApoA) synthesis reducer .

HY-153491

Olezarsen ISIS 678354; IONIS-APOCIII-LRx; AKCEA-APOCIII-LRx		Antisense Oligonucleotides
Olezarsen is an N-acetyl-galactosamine-conjugated antisense oligonucleotide targeted to hepatic APOC3 mRNA to inhibit apolipoprotein C-III (apoC-III) production, in lowering triglyceride levels in patients at high risk for or with established cardiovascular disease.

HY-151123

Pelacarsen AKCEA-APO(a)-LRx; ISIS 681257; TQJ230		Antisense Oligonucleotides
Pelacarsen (AKCEA-APO(a)-LRx) is a liver-specific antisense oligonucleotide against *apolipoprotein(a)* that reduces lipoprotein(a) up to 80% with good tolerability .

HY-153491A

Olezarsen sodium ISIS 678354 sodium; IONIS-APOCIII-LRx sodium; AKCEA-APOCIII-LRx sodium		Antisense Oligonucleotides
Olezarsen sodium is an N-acetyl-galactosamine-conjugated antisense oligonucleotide targeted to hepatic APOC3 mRNA to inhibit apolipoprotein C-III (apoC-III) production, in lowering triglyceride levels in patients at high risk for or with established cardiovascular disease.

HY-148647

Mipomersen ISIS 301012 free base		Antisense Oligonucleotides
Mipomersen (ISIS 301012 free base) is an antisense oligonucleotide inhibitor of apolipoprotein B (apoB). Mipomersen has anti-HCV effect and reduces the infectivity of the HCV. Mipomersen can be used for the research of homozygous familial hypercholesterolemia (HoFH) .

HY-145727

Volanesorsen ISIS 304801		Antisense Oligonucleotides
Volanesorsen (ISIS 304801) is an antisense oligonucleotide inhibitor of apolipoprotein CIII (apo-CIII) mRNA that reduces triglyceride levels and improves insulin resistance. Volanesorsen is being studied in the treatment of hypertriglyceridemia, familial chylosiderosis syndrome, and type 2 diabetes .

Inquiry Online

Your information is safe with us. * Required Fields.

MCE Japan Authorized Agent ナミキ商事株式会社コスモ・バイオ株式会社
Salutation			Country or Region *
Applicant Name *			Organization Name *
Department *
Email Address *			Product Name *
Cat. No.			Requested quantity *
Phone Number *
Remarks

Inquiry Online

Inquiry Information

Product Name:
Cat. No.:
Quantity:
MCE Japan Authorized Agent:

Apolipoprotein

Inhibitors & Agonists

Peptides

NaturalProducts

Recombinant Proteins

Isotope-Labeled Compounds

Antibodies

Oligonucleotides

Natural
Products